Discovery and targeted mass spectrometry-based proteomics: Enabling technologies advancing IRAK4 protein degrader along the drug discovery pipeline into the clinic
Area of Focus
Platform
Targeted Protein Degradation
Programs
Other
Development Stage
Pre-clinical Data
Share
